FFFMX
Price
$64.27
Change
+$0.34 (+0.53%)
Updated
Sep 11 closing price
Net Assets
117.47B
LCEVX
Price
$19.48
Change
+$0.11 (+0.57%)
Updated
Sep 11 closing price
Net Assets
10.41B
Interact to see
Advertisement

FFFMX vs LCEVX

FFFMX vs LCEVX Comparison Chart in %
View a ticker or compare two or three
VS
FFFMX vs. LCEVX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FFFMX is a Buy and LCEVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FFFMX has more cash in the bank: 117B vs. LCEVX (10.4B). FFFMX pays higher dividends than LCEVX: FFFMX (1.66) vs LCEVX (0.47). FFFMX was incepted earlier than LCEVX: FFFMX (6 years) vs LCEVX (25 years). LCEVX (1.58) is less costly to investors than FFFMX (0.32). LCEVX is a more actively managed with annual turnover of: 56.00 vs. FFFMX (30.00). FFFMX has a lower initial minimum investment than LCEVX: FFFMX (250) vs LCEVX (1000). FFFMX annual gain was more profitable for investors over the last year : 5.44 vs. LCEVX (0.54). FFFMX return over 5 years is better than : 39.87 vs. LCEVX (-7.80).
FFFMXLCEVXFFFMX / LCEVX
Total Expense Ratio0.321.5820%
Annual Report Gross Expense Ratio0.321.5820%
Fund Existence6 years25 years-
Gain YTD8.9958.396107%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets117B10.4B1,125%
Annual Yield % from dividends1.660.47355%
Returns for 1 year5.440.541,015%
Returns for 3 years37.9513.37284%
Returns for 5 years39.87-7.80-511%
Returns for 10 yearsN/A17.23-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BBGLX27.430.25
+0.92%
Bridge Builder Large Cap Growth
AVDNX17.850.13
+0.73%
Avantis® International Equity G
SPGRX24.72N/A
N/A
DWS Equity Sector Strategy Fund Class S
VCSTX46.89N/A
N/A
VALIC Company I Science & Technology
VREMX7.73N/A
N/A
Virtus SGA Emerging Markets Equity R6